BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28489557)

  • 1. Reduced bone mineral density in Chinese children with phenylketonuria.
    Wang K; Shen M; Li H; Li X; He C
    J Pediatr Endocrinol Metab; 2017 May; 30(6):651-656. PubMed ID: 28489557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between lumbar bone mineral density and biochemical parameters in phenylketonuria patients.
    de Groot MJ; Hoeksma M; van Rijn M; Slart RH; van Spronsen FJ
    Mol Genet Metab; 2012 Apr; 105(4):566-70. PubMed ID: 22300845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased bone mineral density in children with phenylketonuria.
    Allen JR; Humphries IR; Waters DL; Roberts DC; Lipson AH; Howman-Giles RG; Gaskin KJ
    Am J Clin Nutr; 1994 Feb; 59(2):419-22. PubMed ID: 8310995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal vitamin D levels and bone mineral density among children with inborn errors of metabolism consuming medical food-based diets.
    Geiger KE; Koeller DM; Harding CO; Huntington KL; Gillingham MB
    Nutr Res; 2016 Jan; 36(1):101-8. PubMed ID: 26773786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid profile in patients with phenylketonuria and its relationship with bone mineral density.
    Lage S; Bueno M; Andrade F; Prieto JA; Delgado C; Legarda M; Sanjurjo P; Aldámiz-Echevarría LJ
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S363-71. PubMed ID: 20830525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral density in patients with phenylketonuria.
    Zeman J; Bayer M; Stepán J
    Acta Paediatr; 1999 Dec; 88(12):1348-51. PubMed ID: 10626520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peak bone mass in patients with phenylketonuria.
    Modan-Moses D; Vered I; Schwartz G; Anikster Y; Abraham S; Segev R; Efrati O
    J Inherit Metab Dis; 2007 Apr; 30(2):202-8. PubMed ID: 17347917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of bone mineral density and fractures in phenylketonuria.
    Hansen KE; Ney D
    J Inherit Metab Dis; 2014 Nov; 37(6):875-80. PubMed ID: 25005329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Markers of bone formation and resorption in prepubertal children with phenylketonuria].
    Ambroszkiewicz J; Gajewska J; Laskowska-Klita T
    Med Wieku Rozwoj; 2003; 7(1):89-95. PubMed ID: 13130173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased bone mineralization in children with phenylketonuria under treatment.
    Hillman L; Schlotzhauer C; Lee D; Grasela J; Witter S; Allen S; Hillman R
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S148-52. PubMed ID: 8828633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone development in children and adolescents with PKU.
    Mendes AB; Martins FF; Cruz WM; da Silva LE; Abadesso CB; Boaventura GT
    J Inherit Metab Dis; 2012 May; 35(3):425-30. PubMed ID: 22076426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral status in children with phenylketonuria under treatment.
    Al-Qadreh A; Schulpis KH; Athanasopoulou H; Mengreli C; Skarpalezou A; Voskaki I
    Acta Paediatr; 1998 Nov; 87(11):1162-6. PubMed ID: 9846918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased trabecular bone mineral density in patients with phenylketonuria measured by peripheral quantitative computed tomography.
    Schwahn B; Mokov E; Scheidhauer K; Lettgen B; Schönau E
    Acta Paediatr; 1998 Jan; 87(1):61-3. PubMed ID: 9510449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated plasma phenylalanine concentrations may adversely affect bone status of phenylketonuric mice.
    Yannicelli S; Medeiros DM
    J Inherit Metab Dis; 2002 Sep; 25(5):347-61. PubMed ID: 12408184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
    Diamond A; Prevor MB; Callender G; Druin DP
    Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density is within normal range in most adult phenylketonuria patients.
    Lubout CMA; Arrieta Blanco F; Bartosiewicz K; Feillet F; Gizewska M; Hollak C; van der Lee JH; Maillot F; Stepien KM; Wagenmakers MAEM; Welsink-Karssies MM; van Spronsen FJ; Bosch AM
    J Inherit Metab Dis; 2020 Mar; 43(2):251-258. PubMed ID: 31587319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary glycemic index, glycemic load and metabolic profile in children with phenylketonuria.
    Moretti F; Pellegrini N; Salvatici E; Rovelli V; Banderali G; Radaelli G; Scazzina F; Giovannini M; Verduci E
    Nutr Metab Cardiovasc Dis; 2017 Feb; 27(2):176-182. PubMed ID: 28081989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria.
    Dobbelaere D; Michaud L; Debrabander A; Vanderbecken S; Gottrand F; Turck D; Farriaux JP
    J Inherit Metab Dis; 2003; 26(1):1-11. PubMed ID: 12872834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone metabolism in adults with phenylketonuria - Hungarian data].
    Barta AG; Sumánszki C; Reismann P
    Orv Hetil; 2017 Nov; 158(47):1868-1872. PubMed ID: 29153023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of bone mineral density and selected metabolic markers of bone in boys with constitutional delay of growth and puberty].
    Krupa B
    Ann Acad Med Stetin; 2000; 46():165-76. PubMed ID: 11712302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.